I-Tech, the originator of Selektope, a marine biocide used to improve ship hull performance and reduce maintenance, has been notified that Selektope has passed the EU evaluation criteria for marine biocides and therefore can be authorized for approval in the EU.
The authorization from the UK HSE means that all necessary investigations and tests are completed, approved and evaluated to ensure that Selektope does not pose a risk to humans or the environment when used as an antifouling biocide.
All other EU member states have now received access to the Selektope dossier and will be given the opportunity to raise questions or concerns during a 2-month period.
Final EU approval is estimated to arrive by the end of 2014. Selektope has already received regulatory approval in Japan, Korea and is under registration in China.
“The confirmation that Selektope complies with the demanding EU Biocidal Products Regulation for its use is very encouraging to us as the EU requirements are utmost stringent and serve as references for regulators and industry in most parts of the world. We are confident that our enthusiasm is shared also by our customers and partners in the shipping industry as this is proof that Selektope is a safe and well-evaluated product”, says Philip Chaabane, Managing Director of I-Tech.
Selektope – further improving antifouling paints
Selektope is a biodegradable, non-metal substance developed to avoid fouling on boats and ships by barnacles and other shell-forming animals – a so-called antifouling substance.
It has proven effectiveness in concentrations of about 0.1 % w/w (percentage weight/weight).
The antifouling effect is exerted through stimulation of the barnacle larvae’s swimming behaviour. It thereby makes the larvae unable to attach to a surface painted with Selektope.
As soon as the barnacle leaves the surface the effect disappears, i.e. it is reversible. Due to the low concentration needed, Selektope does not compromise the paint’s chemical structure, colour or other cooperative biocides involved.
Press Release, July 9th, 2014